JP
Merck just released a statement confirming the $4.85 million settlement agreement covering the majority of liability cases against the company over Vioxx. The drug maker takes pains to say this is not a class-action settlement, but instead establishes a fund that will be doled out case by case.
Here’s the way Merck tells it, […]
Continued Read ...
JP
Merck just released a statement confirming the $4.85 million settlement agreement covering the majority of liability cases against the company over Vioxx. The drug maker takes pains to say this is not a class-action settlement, but instead establishes a fund that will be doled out case by case.
Key criteria for plaintiffs to qualify […]
Continued Read ...
Scott Hensley
Merck just released a statement confirming the $4.85 million settlement agreement covering the majority of liability cases against the company over Vioxx. The drug maker takes pains to say this is not a class-action settlement, but instead establishes a fund that will be doled out case by case.
The first criterion for plaintiffs […]
Continued Read ...
